The harsh realities facing the use of SPECT imaging in monitoring disease progression in Parkinson’s disease

[...]the UPDRS scores were influenced by dopaminergic drug effects and therefore were not suitable to study correlations with [123I][beta]-CIT SPECT measures.

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of neurology, neurosurgery and psychiatry neurosurgery and psychiatry, 2003-10, Vol.74 (10), p.1447-1447
1. Verfasser:	Morrish, P K
Format:	Artikel
Sprache:	eng
Schlagworte:	Acquisitions & mergers Antiparkinson Agents - pharmacology Clinical Trials as Topic Correspondence Disease Progression Dopamine Endpoint Determination Humans Neuroprotective Agents - pharmacology Parkinson Parkinson Disease - diagnostic imaging Parkinson Disease - pathology Parkinson's disease Reproducibility of Results s disease Sensitivity and Specificity SPECT Studies Substance abuse treatment Tomography, Emission-Computed, Single-Photon
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	[...]the UPDRS scores were influenced by dopaminergic drug effects and therefore were not suitable to study correlations with [123I][beta]-CIT SPECT measures.
ISSN:	0022-3050 1468-330X
DOI:	10.1136/jnnp.74.10.1447